Back
Celldex Therapeutics Vs. Smith-Midland Industry Stock Comparison
Buy
57
CLDX
Celldex Therapeutics
Last Price:
41.86
Seasonality Move:
-0.32%
Buy
53
SMID
Smith-Midland
Last Price:
37.12
Seasonality Move:
6.8%
Buy
57
Celldex Therapeutics (CLDX)
is a Buy
Is Celldex Therapeutics a Buy, Sell or Hold?
- The current Celldex Therapeutics [CLDX] share price is $41.24. The Score for CLDX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- CLDX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
53
Smith-Midland (SMID)
is a Buy
Is Smith-Midland a Buy, Sell or Hold?
- The current Smith-Midland [SMID] share price is $36.62. The Score for SMID is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- SMID is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CLDX Stock Price Chart
What is Celldex Therapeutics's stock price today?
-
The Celldex Therapeutics share price today is $41.24
The current trend is moderately bullish and CLDX is experiencing selling pressure, which indicates risk of future bearish movement.
SMID Stock Price Chart
What is Smith-Midland's stock price today?
-
The Smith-Midland share price today is $36.62
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SMID is experiencing buying pressure, which is a positive indicator for future bullish movement.
CLDX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.61 | Buy |
Relative Strength Index (14 RSI): | 54.37 | Buy |
Chaikin Money Flow: | -978428 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (35.34 - 42.86) | Buy |
Bollinger Bands (100): | (34.47 - 40.83) | Buy |
SMID Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.66 | Buy |
Relative Strength Index (14 RSI): | 61.07 | Buy |
Chaikin Money Flow: | 30842 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (30.64 - 34.92) | Buy |
Bollinger Bands (100): | (29.7 - 36.08) | Buy |
CLDX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 42.47 | Sell |
20-day SMA: | 40.46 | Buy |
50-day SMA: | 38.27 | Buy |
200-day SMA: | 38.61 | Buy |
8-day EMA: | 42.17 | Sell |
20-day EMA: | 40.7 | Buy |
50-day EMA: | 38.89 | Buy |
200-day EMA: | 37.46 | Buy |
SMID Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 32.87 | Buy |
20-day SMA: | 33.22 | Buy |
50-day SMA: | 31.84 | Buy |
200-day SMA: | 36.39 | Buy |
8-day EMA: | 33.85 | Buy |
20-day EMA: | 32.95 | Buy |
50-day EMA: | 32.52 | Buy |
200-day EMA: | 32.78 | Buy |
Celldex Therapeutics Earnings Growth & CLDX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.18 per share, an increase this year of $0.19 per share, and a decrease next year of $0.66 per share.
Smith-Midland Earnings Growth & SMID Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Celldex Therapeutics Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Smith-Midland Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |